new
Wednesday 11th February 2015
‘What happens when mega pharmaceutical companies get their new grip
around one of the oldest asthma medications that many rely on for daily
use? Based on historical data, it appears that one of the first action
items is to exponentially increase the price of the same medication
without any actual advancements of any kind. It’s a process that is
involved with ‘repatenting.’
The art of repatenting is one that massive corporations absolutely
love. When the drug companies own the patent rights to a formula, even
if it is virtually the same as a generic one or has been sold for far
less over the last several decades, they can charge you (and your
insurance company) whatever they want. And in the case of the highly
popular asthma drug albuterol, even the New York Times has reported on
the absurd price increase following its ‘repatenting.’’
Read more
No comments:
Post a Comment